Ellington Management Group’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-18,800	Closed	-$329K	–	468
2018 Q1	$329K	Buy	+18,800	New	+$329K	0.02%	540
2016 Q4	–	Sell	-9,117	Closed	-$233K	–	512
2016 Q3	$233K	Buy	+9,117	New	+$233K	0.06%	490